Narges Dargahi
Overview
Explore the profile of Narges Dargahi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Devereaux J, Robinson A, Stavely R, Davidson M, Dargahi N, Ephraim R, et al.
Front Med (Lausanne)
. 2024 Jul;
11:1379335.
PMID: 39015786
Background: Inflammatory bowel disease is an incurable and idiopathic disease characterized by recurrent gastrointestinal tract inflammation. Tryptophan metabolism in mammalian cells and some gut microbes comprise intricate chemical networks facilitated...
2.
Chavda V, Vuppu S, Mishra T, Kamaraj S, Sharma N, Punetha S, et al.
Expert Rev Vaccines
. 2024 Feb;
23(1):246-265.
PMID: 38372023
Introduction: The escalating prevalence of infectious diseases is an important cause of concern in society. Particularly in several developing countries, infectious diarrhea poses a major problem, with a high fatality...
3.
Mikkelsen K, Dargahi N, Fraser S, Apostolopoulos V
Biomedicines
. 2023 Sep;
11(9).
PMID: 37761018
Vitamin B6 is shown to have anti-inflammatory properties, which makes it an interesting nutraceutical agent. Vitamin B6 deficiency is well established as a contributor to inflammatory-related conditions, whilst B6 supplementation...
4.
Timpani C, Kourakis S, Debruin D, Campelj D, Pompeani N, Dargahi N, et al.
JCI Insight
. 2023 Sep;
8(21.
PMID: 37751291
New medicines are urgently required to treat the fatal neuromuscular disease Duchenne muscular dystrophy (DMD). Dimethyl fumarate (DMF) is a potent immunomodulatory small molecule nuclear erythroid 2-related factor 2 activator...
5.
Filippone R, Dargahi N, Eri R, Uranga J, Bornstein J, Apostolopoulos V, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887133
Eosinophils and their regulatory molecules have been associated with chronic intestinal inflammation and gastrointestinal dysfunctions; eosinophil accumulation in the gut is prominent in inflammatory bowel disease (IBD). The chemokine receptor...
6.
Devereaux J, Dargahi N, Fraser S, Nurgali K, Kiatos D, Apostolopoulos V
Int J Mol Sci
. 2020 Sep;
21(18).
PMID: 32900003
Background: Platelet-rich plasma (PRP) is an autologous blood product that contains a high concentration of platelets and leucocytes, which are fundamental fibroblast proliferation agents. Literature has emerged that offers contradictory...
7.
Dargahi N, Matsoukas J, Apostolopoulos V
Brain Sci
. 2020 Feb;
10(2).
PMID: 32102262
Probiotic bacteria have beneficial effects to the development and maintenance of a healthy microflora that subsequently has health benefits to humans. Some of the health benefits attributed to probiotics have...
8.
Dargahi N, Johnson J, Apostolopoulos V
PLoS One
. 2020 Feb;
15(2):e0228531.
PMID: 32045425
Consumption of probiotics contributes to a healthy microbiome of the GIT leading to many health benefits. They also contribute to the modulation of the immune system and are becoming popular...
9.
Immunomodulatory effects of probiotics: Can they be used to treat allergies and autoimmune diseases?
Dargahi N, Johnson J, Donkor O, Vasiljevic T, Apostolopoulos V
Maturitas
. 2018 Dec;
119:25-38.
PMID: 30502748
As a person ages, physiological, immunological and gut microbiome changes collectively result in an array of chronic conditions. According to the 'hygiene hypothesis' the increasing prevalence of immune-mediated disorders may...
10.
Dargahi N, Katsara M, Tselios T, Androutsou M, de Courten M, Matsoukas J, et al.
Brain Sci
. 2017 Jul;
7(7).
PMID: 28686222
The treatment of multiple sclerosis (MS) has changed over the last 20 years. All immunotherapeutic drugs target relapsing remitting MS (RRMS) and it still remains a medical challenge in MS...